ICU Medical Gross Margin 2012-2026 | ICUI
Current and historical gross margin for ICU Medical (ICUI) over the last 10 years. The current gross profit margin for ICU Medical as of June 30, 2026 is %.
| ICU Medical Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2026-06-30 | $2.16B | $0.85B | 39.12% |
| 2026-03-31 | $2.16B | $0.82B | 37.92% |
| 2025-12-31 | $2.23B | $0.82B | 36.83% |
| 2025-09-30 | $2.32B | $0.85B | 36.45% |
| 2025-06-30 | $2.37B | $0.85B | 35.82% |
| 2025-03-31 | $2.42B | $0.85B | 35.08% |
| 2024-12-31 | $2.38B | $0.82B | 34.59% |
| 2024-09-30 | $2.34B | $0.77B | 32.86% |
| 2024-06-30 | $2.30B | $0.75B | 32.47% |
| 2024-03-31 | $2.26B | $0.73B | 32.48% |
| 2023-12-31 | $2.26B | $0.74B | 32.76% |
| 2023-09-30 | $2.25B | $0.74B | 33.04% |
| 2023-06-30 | $2.29B | $0.75B | 32.48% |
| 2023-03-31 | $2.31B | $0.72B | 31.27% |
| 2022-12-31 | $2.28B | $0.70B | 30.61% |
| 2022-09-30 | $2.04B | $0.65B | 31.82% |
| 2022-06-30 | $1.78B | $0.59B | 33.24% |
| 2022-03-31 | $1.54B | $0.55B | 35.54% |
| 2021-12-31 | $1.32B | $0.49B | 37.36% |
| 2021-09-30 | $1.30B | $0.49B | 37.42% |
| 2021-06-30 | $1.28B | $0.47B | 36.83% |
| 2021-03-31 | $1.26B | $0.45B | 35.95% |
| 2020-12-31 | $1.27B | $0.46B | 36.27% |
| 2020-09-30 | $1.27B | $0.46B | 35.91% |
| 2020-06-30 | $1.26B | $0.46B | 36.65% |
| 2020-03-31 | $1.26B | $0.46B | 36.23% |
| 2019-12-31 | $1.27B | $0.47B | 37.28% |
| 2019-09-30 | $1.29B | $0.49B | 38.22% |
| 2019-06-30 | $1.31B | $0.51B | 38.85% |
| 2019-03-31 | $1.36B | $0.56B | 41.02% |
| 2018-12-31 | $1.40B | $0.57B | 40.81% |
| 2018-09-30 | $1.43B | $0.57B | 40.10% |
| 2018-06-30 | $1.45B | $0.55B | 38.06% |
| 2018-03-31 | $1.42B | $0.49B | 34.30% |
| 2017-12-31 | $1.29B | $0.43B | 32.95% |
| 2017-09-30 | $1.02B | $0.34B | 33.37% |
| 2017-06-30 | $0.77B | $0.28B | 36.09% |
| 2017-03-31 | $0.54B | $0.24B | 44.80% |
| 2016-12-31 | $0.38B | $0.20B | 52.89% |
| 2016-09-30 | $0.37B | $0.20B | 52.94% |
| 2016-06-30 | $0.36B | $0.19B | 53.17% |
| 2016-03-31 | $0.35B | $0.19B | 53.43% |
| 2015-12-31 | $0.34B | $0.18B | 53.08% |
| 2015-09-30 | $0.33B | $0.17B | 52.27% |
| 2015-06-30 | $0.32B | $0.17B | 51.24% |
| 2015-03-31 | $0.32B | $0.16B | 50.16% |
| 2014-12-31 | $0.31B | $0.15B | 49.19% |
| 2014-09-30 | $0.31B | $0.15B | 49.19% |
| 2014-06-30 | $0.31B | $0.15B | 49.20% |
| 2014-03-31 | $0.31B | $0.15B | 49.20% |
| 2013-12-31 | $0.31B | $0.16B | 49.36% |
| 2013-09-30 | $0.32B | $0.16B | 49.53% |
| 2013-06-30 | $0.32B | $0.16B | 49.84% |
| 2013-03-31 | $0.32B | $0.16B | 50.48% |
| 2012-12-31 | $0.32B | $0.16B | 49.53% |
| 2012-09-30 | $0.31B | $0.15B | 48.71% |
| 2012-06-30 | $0.31B | $0.15B | 47.87% |
| 2012-03-31 | $0.31B | $0.14B | 46.73% |
| 2011-12-31 | $0.30B | $0.14B | 47.51% |
| 2011-09-30 | $0.30B | $0.14B | 47.83% |
| 2011-06-30 | $0.30B | $0.14B | 47.16% |
| 2011-03-31 | $0.29B | $0.14B | 47.24% |
| 2010-12-31 | $0.28B | $0.13B | 45.58% |
| 2010-09-30 | $0.28B | $0.12B | 44.20% |
| 2010-06-30 | $0.25B | $0.11B | 44.49% |
| 2010-03-31 | $0.24B | $0.11B | 44.96% |
| 2009-12-31 | $0.23B | $0.11B | 46.93% |
| 2009-09-30 | $0.22B | $0.10B | 47.71% |
| 2009-06-30 | $0.22B | $0.10B | 47.49% |
| 2009-03-31 | $0.22B | $0.10B | 46.05% |
| 2008-12-31 | $0.21B | $0.09B | 43.69% |
| 2008-09-30 | $0.20B | $0.08B | 42.56% |
| 2008-06-30 | $0.19B | $0.08B | 41.62% |
| 2008-03-31 | $0.19B | $0.08B | 41.62% |
| 2007-12-31 | $0.19B | $0.08B | 41.27% |
| 2007-09-30 | $0.20B | $0.08B | 38.78% |
| 2007-06-30 | $0.20B | $0.08B | 38.00% |
| 2007-03-31 | $0.20B | $0.08B | 38.61% |
| 2006-12-31 | $0.20B | $0.08B | 39.60% |
| 2006-09-30 | $0.19B | $0.08B | 42.71% |
| 2006-06-30 | $0.19B | $0.08B | 43.16% |
| 2006-03-31 | $0.18B | $0.08B | 41.67% |
| 2005-12-31 | $0.16B | $0.07B | 43.67% |
| 2005-09-30 | $0.13B | $0.06B | 42.31% |
| 2005-06-30 | $0.10B | $0.04B | 43.43% |
| 2005-03-31 | $0.08B | $0.04B | 48.75% |
| 2004-12-31 | $0.08B | $0.04B | 48.00% |
| 2004-09-30 | $0.09B | $0.05B | 53.33% |
| 2004-06-30 | $0.10B | $0.05B | 53.00% |
| 2004-03-31 | $0.10B | $0.05B | 53.54% |
| 2003-12-31 | $0.11B | $0.06B | 54.63% |
| 2003-09-30 | $0.10B | $0.06B | 54.90% |
| 2003-06-30 | $0.10B | $0.06B | 58.33% |
| 2003-03-31 | $0.10B | $0.06B | 58.16% |
| 2002-12-31 | $0.09B | $0.05B | 57.95% |
| 2002-09-30 | $0.09B | $0.05B | 57.65% |
| 2002-06-30 | $0.08B | $0.05B | 56.79% |
| 2002-03-31 | $0.08B | $0.04B | 57.33% |
| 2001-12-31 | $0.07B | $0.04B | 57.97% |
| 2001-09-30 | $0.07B | $0.04B | 58.46% |
| 2001-06-30 | $0.06B | $0.04B | 57.38% |
| 2001-03-31 | $0.06B | $0.03B | 56.90% |
| 2000-12-31 | $0.06B | $0.03B | 56.14% |
| 2000-09-30 | $0.05B | $0.03B | 56.60% |
| 2000-06-30 | $0.05B | $0.03B | 57.69% |
| 2000-03-31 | $0.05B | $0.03B | 58.00% |
| 1999-12-31 | $0.05B | $0.03B | 59.57% |
| 1999-09-30 | $0.04B | $0.03B | 59.09% |
| 1999-06-30 | $0.04B | $0.03B | 60.47% |
| 1999-03-31 | $0.04B | $0.03B | 60.98% |
| 1998-12-31 | $0.04B | $0.02B | 60.00% |
| 1998-09-30 | $0.04B | $0.03B | 69.23% |
| 1998-06-30 | $0.04B | $0.03B | 75.68% |
| 1998-03-31 | $0.03B | $0.03B | 76.47% |
| 1997-12-31 | $0.03B | $0.02B | 77.42% |
| 1997-09-30 | $0.03B | $0.02B | 75.00% |
| 1997-06-30 | $0.03B | $0.02B | 65.38% |
| 1997-03-31 | $0.03B | $0.02B | 64.00% |
| 1996-12-31 | $0.02B | $0.02B | 75.00% |
| 1996-09-30 | $0.02B | $0.02B | 65.22% |
| 1996-06-30 | $0.02B | $0.01B | 63.64% |
| 1996-03-31 | $0.02B | $0.01B | 63.64% |
| 1995-12-31 | $0.02B | $0.01B | 47.62% |
| 1995-09-30 | $0.02B | $0.01B | 42.86% |
| 1995-06-30 | $0.02B | $0.01B | 42.11% |
| 1995-03-31 | $0.02B | $0.01B | 41.18% |
| 1994-12-31 | $0.02B | $0.01B | 50.00% |
| 1994-09-30 | $0.02B | $0.01B | 53.33% |
| 1994-06-30 | $0.01B | $0.01B | 57.14% |
| 1994-03-31 | $0.01B | $0.01B | 58.33% |
| 1993-12-31 | $0.01B | $0.01B | 54.55% |
| 1993-09-30 | $0.01B | $0.01B | 60.00% |
| 1993-06-30 | $0.01B | $0.01B | 63.64% |
| 1993-03-31 | $0.01B | $0.01B | 72.73% |
| 1992-12-31 | $0.01B | $0.01B | 80.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $3.896B | $2.231B |
| ICU Medical, Inc. develops, manufactures and sells innovative medical devices used in vascular therapy, oncology and critical care applications. They are one of the world's leading pure-play infusion therapy companies, with global operations and a wide-ranging product portfolio that includes IV solutions, IV smart pumps, dedicated and non-dedicated IV sets and needlefree connectors, along with pain management and safety software technology designed to help meet clinical, safety and workflow goals. In addition, they manufacture automated pharmacy IV compounding systems with workflow technology, closed systems transfer devices for hazardous IV drugs, and cardiac monitoring systems to optimize patient fluid levels. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $176.551B | 19.40 |
| Medtronic (MDT) | Ireland | $119.919B | 16.39 |
| Stryker (SYK) | United States | $107.976B | 20.18 |
| EssilorLuxottica (ESLOY) | France | $77.566B | 0.00 |
| Boston Scientific (BSX) | United States | $63.578B | 13.67 |
| Lonza Group Ag (LZAGY) | Switzerland | $46.123B | 0.00 |
| Agilent Technologies (A) | United States | $42.365B | 24.80 |
| Medline (MDLN) | United States | $42.215B | 0.00 |
| ResMed (RMD) | United States | $33.097B | 20.54 |
| GE HealthCare Technologies (GEHC) | United States | $28.940B | 13.84 |
| Koninklijke Philips (PHG) | Netherlands | $24.474B | 13.04 |
| Terumo (TRUMY) | Japan | $21.278B | 20.32 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.771B | 11.60 |
| Baxter (BAX) | United States | $12.258B | 11.57 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.762B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $10.107B | 40.73 |
| Demant (WILYY) | Denmark | $9.694B | 0.00 |
| Insulet (PODD) | United States | $9.657B | 23.72 |
| Sunny Optical Technology (SNPTF) | China | $9.142B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.575B | 20.23 |
| Raia Drogasil SA - (RADLY) | $4.998B | 0.00 | |
| BillionToOne (BLLN) | United States | $4.920B | 148.96 |
| Haemonetics (HAE) | United States | $4.832B | 21.20 |
| DiaSorin S.p.A (DSRLF) | Italy | $4.705B | 0.00 |
| Envista Holdings (NVST) | United States | $3.972B | 16.82 |
| AtriCure (ATRC) | United States | $2.860B | 244.43 |
| Neogen (NEOG) | United States | $2.672B | 47.12 |
| Curaleaf Holdings (CURLD) | Canada | $2.388B | 0.00 |
| Curaleaf Holdings (CURLF) | United States | $2.363B | 0.00 |
| Trulieve Cannabis (TRLV) | United States | $2.234B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $2.214B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $2.211B | 10.56 |
| Perrigo (PRGO) | Ireland | $1.882B | 5.42 |
| LeMaitre Vascular (LMAT) | United States | $1.835B | 29.50 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $1.798B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.787B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.780B | 227.44 |
| Kestra Medical Technologies (KMTS) | United States | $1.500B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.445B | 15.42 |
| Phibro Animal Health (PAHC) | United States | $1.422B | 10.91 |
| Omeros (OMER) | United States | $1.243B | 6.29 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.131B | 0.00 |
| CeriBell (CBLL) | United States | $0.961B | 0.00 |
| InMode (INMD) | Israel | $0.855B | 11.90 |
| AdaptHealth (AHCO) | United States | $0.794B | 16.63 |
| VAREX IMAGING (VREX) | United States | $0.778B | 17.10 |
| Glass House Brands (GLAS) | United States | $0.754B | 0.00 |
| QuidelOrtho (QDEL) | United States | $0.729B | 7.87 |
| Valneva SE (VALN) | France | $0.622B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.561B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.543B | 0.00 |
| Brainsway (BWAY) | Israel | $0.541B | 30.59 |
| Evolus (EOLS) | United States | $0.522B | 0.00 |
| Cerus (CERS) | United States | $0.504B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.498B | 0.00 |
| Vireo Growth (VREOD) | United States | $0.451B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.441B | 0.00 |
| Verano Holdings (VRNOD) | United States | $0.425B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.413B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.395B | 8.28 |
| Cresco Labs (CRLBF) | United States | $0.372B | 0.00 |
| SNDL (SNDL) | Canada | $0.347B | 0.00 |
| Village Farms (VFF) | Canada | $0.347B | 15.78 |
| Viemed Healthcare (VMD) | United States | $0.333B | 24.31 |
| Sanara MedTech (SMTI) | United States | $0.323B | 159.59 |
| TriSalus Life Sciences (TLSI) | United States | $0.294B | 0.00 |
| MacroGenics (MGNX) | United States | $0.257B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.248B | 13.17 |
| OraSure Technologies (OSUR) | United States | $0.239B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.238B | 22.75 |
| High Tide (HITI) | Canada | $0.226B | 50.80 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| TerrAscend (TSNDF) | Canada | $0.200B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.192B | 0.00 |
| Exagen (XGN) | United States | $0.181B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| Jin Medical (ZJYL) | China | $0.156B | 0.00 |
| Organigram Global (OGI) | Canada | $0.149B | 0.00 |
| Quanterix (QTRX) | United States | $0.129B | 0.00 |
| Apyx Medical (APYX) | United States | $0.125B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.53 |
| FitLife Brands (FTLF) | United States | $0.087B | 11.48 |
| ImmuCell (ICCC) | United States | $0.087B | 119.75 |
| Accendra Health (ACH) | United States | $0.085B | 4.83 |
| Jushi Holdings (JUSHF) | United States | $0.083B | 0.00 |
| Sharps Technology (STSS) | United States | $0.065B | 0.00 |
| InterCure (INCR) | Israel | $0.056B | 0.00 |
| Hongchang (HCIL) | China | $0.055B | 0.00 |
| Biote (BTMD) | United States | $0.050B | 4.09 |
| Nephros (NEPH) | United States | $0.047B | 39.00 |
| Veru (VERU) | United States | $0.040B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.035B | 17.12 |
| United-Guardian (UG) | United States | $0.033B | 13.22 |
| Rockwell Medical (RMTI) | United States | $0.032B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.022B | 0.00 |
| Modular Medical (MODD) | United States | $0.020B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.019B | 0.00 |
| Bonk (BNKK) | United States | $0.010B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.006B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Agape ATP (ATPC) | $0.002B | 0.00 | |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.001B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.000B | 0.00 |
| INLIF (INLF) | China | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |